PAM
NTGN

Panagora Asset Management’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Panagora Asset Management’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,029
Closed -$16K – 2729
2020
Q1 		$16K Buy
+6,029
New +$9.89K ﹤0.01% 2083

Panagora Asset Management's NTGN Position: Q2 2020 in Review

Panagora Asset Management sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 6,029 shares — an estimated $16K sold.

Panagora Asset Management first reported a position in NTGN in Q1 2020 and held it in 1 quarter. The position peaked at $16K in Q1 2020. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

  • Panagora Asset Management reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Panagora Asset Management sold 6,029 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $16K.
  • Panagora Asset Management first reported a position in Neon Therapeutics, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Panagora Asset Management's Neon Therapeutics, Inc. Common Stock position peaked at $16K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Panagora Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.